Live Webcast of the announcement of RP101 Phase II clinical results

Redwood Pharma and Prof. Gerhard Garhöfer of the Medical University of Vienna, Austria invite you to listen to the live presentation at 10:30 am CET today March 12, 2020 of the results of the RP101 Phase II clinical trial following this morning’s formal press release.

The presentation will be held at the location: Kungstornen Konferens center, Kungsgatan 33, 2 tr, 111 56 Stockholm.

To view the webcast and ask questions, please follow the link:

Webcast viewers can submit questions for the presenters via the webcast.